Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Association between proto-oncogene mutations and clinicopathologic characteristics and overall survival in colorectal cancer in East Azerbaijan, Iran.

Dolatkhah R, Somi MH, Asvadi Kermani I, Bonyadi M, Sepehri B, Boostani K, Azadbakht S, Fotouhi N, Farassati F, Dastgiri S.

Onco Targets Ther. 2016 Dec 7;9:7385-7395. eCollection 2016.

2.

Can Opium Use Contribute to a Higher Risk of Colorectal Cancers? A Matched Case-control Study in Iran.

Naghibzadeh-Tahami A, Yazdi Feyzabadi V, Khanjani N, Ashrafi-Asgarabad A, Alizaeh H, Borhaninejad VR, Moradi-Joo M, Zeinali M, Zahedi MJ, Aghaee-Afshar M, Haghdoost AA.

Iran J Public Health. 2016 Oct;45(10):1322-1331.

3.

Low Level of Microsatellite Instability Correlates with Poor Clinical Prognosis in Stage II Colorectal Cancer Patients.

Nazemalhosseini Mojarad E, Kashfi SM, Mirtalebi H, Taleghani MY, Azimzadeh P, Savabkar S, Pourhoseingholi MA, Jalaeikhoo H, Asadzadeh Aghdaei H, Kuppen PJ, Zali MR.

J Oncol. 2016;2016:2196703. doi: 10.1155/2016/2196703. Epub 2016 Jun 27.

4.

Evaluation of the left-to-right shift of colon tumors in Iran: Is the trend changing?

Kashfi SM, Nazemalhosseini Mojarad E, Pourhoseingholi MA, Asadzadeh Aghdaei H, Anaraki F, Zali MR.

J Res Med Sci. 2015 Oct;20(10):978-86. doi: 10.4103/1735-1995.172789.

5.

Incidence and Mortality Rate of Common Gastrointestinal Cancers in South of Iran, a Population Based Study.

Hassanzade J, Molavi E Vardanjani H, Farahmand M, Rajaiifard AR.

Iran J Cancer Prev. 2011 Fall;4(4):163-9.

6.

Colorectal cancer in iran: molecular epidemiology and screening strategies.

Dolatkhah R, Somi MH, Bonyadi MJ, Asvadi Kermani I, Farassati F, Dastgiri S.

J Cancer Epidemiol. 2015;2015:643020. doi: 10.1155/2015/643020. Epub 2015 Jan 15. Review.

7.

Age and site of Colonic Neoplastic Lesions: Implications of screening in South Asia.

Hussain M, Khalid AB, Ahsan S, Jafri W, Hamid S, Javed A, Wahab S.

Pak J Med Sci. 2014 Nov-Dec;30(6):1277-80. doi: 10.12669/pjms.306.5701.

8.

Clinicopathological patterns and challenges of management of colorectal cancer in a resource-limited setting: a Tanzanian experience.

Chalya PL, McHembe MD, Mabula JB, Rambau PF, Jaka H, Koy M, Mkongo E, Masalu N.

World J Surg Oncol. 2013 Apr 18;11:88. doi: 10.1186/1477-7819-11-88.

9.

The impact of age on outcome after surgery for colorectal adenocarcinoma.

Widdison AL, Barnett SW, Betambeau N.

Ann R Coll Surg Engl. 2011 Sep;93(6):445-50. doi: 10.1308/003588411X587154.

10.

Colorectal carcinoma in Lagos and Sagamu, Southwest Nigeria: a histopathological review.

Abdulkareem FB, Abudu EK, Awolola NA, Elesha SO, Rotimi O, Akinde OR, Atoyebi AO, Adesanya AA, Daramola AO, Banjo AA, Anunobi CC.

World J Gastroenterol. 2008 Nov 14;14(42):6531-5.

11.

Impact of BRAF, MLH1 on the incidence of microsatellite instability high colorectal cancer in populations based study.

Brim H, Mokarram P, Naghibalhossaini F, Saberi-Firoozi M, Al-Mandhari M, Al-Mawaly K, Al-Mjeni R, Al-Sayegh A, Raeburn S, Lee E, Giardiello F, Smoot DT, Vilkin A, Boland CR, Goel A, Hafezi M, Nouraie M, Ashktorab H.

Mol Cancer. 2008 Aug 21;7:68. doi: 10.1186/1476-4598-7-68.

12.

Clinical predictors of colorectal polyps and carcinoma in a low prevalence region: results of a colonoscopy based study.

Bafandeh Y, Khoshbaten M, Eftekhar Sadat AT, Farhang S.

World J Gastroenterol. 2008 Mar 14;14(10):1534-8.

Supplemental Content

Support Center